Beta-Blocker Use in Asthma Patients

Introduction to Beta-Blocker Contraindications

Propranolol, a non-selective beta-blocker, blocks both beta-1 and beta-2 adrenergic receptors, causing increased airway resistance, bronchoconstriction, and potential severe asthma exacerbations, particularly in patients with a history of asthma 1

The American Heart Association recommends considering highly cardioselective beta-blockers, such as bisoprolol or metoprolol, instead of non-selective beta-blockers, and starting with the lowest possible dose and titrating slowly, while monitoring pulmonary function closely 1

Patients with severe or poorly controlled asthma are at highest risk, and monitoring for increased wheezing, decreased peak flow, increased rescue inhaler use, and nocturnal symptoms is crucial when using cardioselective beta-blockers 2
The American Academy of Otolaryngology-Head and Neck Surgery suggests that patients on beta-blockers may have reduced response to beta-agonist rescue medications if an asthma exacerbation occurs, highlighting the need for careful emergency management 2

Non-selective beta-blockers, including propranolol, timolol, nadolol, and carvedilol, should be avoided in patients with asthma due to the high risk of triggering bronchospasm and potentially life-threatening asthma exacerbations 1